These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31113450)

  • 1. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells.
    Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Cell Death Dis; 2019 May; 10(6):394. PubMed ID: 31113938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
    Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
    Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
    Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
    Shetty PK; Thamake SI; Biswas S; Johansson SL; Vishwanatha JK
    PLoS One; 2012; 7(9):e44299. PubMed ID: 22957061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells.
    Wu B; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Han J; Niu R
    Cell Prolif; 2012 Jun; 45(3):189-98. PubMed ID: 22452352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
    Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
    PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
    Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
    J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
    Dezong G; Zhongbing M; Qinye F; Zhigang Y
    J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.
    Andey T; Marepally S; Patel A; Jackson T; Sarkar S; O'Connell M; Reddy RC; Chellappan S; Singh P; Singh M
    J Control Release; 2014 Jun; 184():67-78. PubMed ID: 24727000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.
    Chaudhary P; Thamake SI; Shetty P; Vishwanatha JK
    Br J Cancer; 2014 Dec; 111(12):2328-41. PubMed ID: 25321192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.
    Long Y; Chong T; Lyu X; Chen L; Luo X; Faleti OD; Deng S; Wang F; He M; Qian Z; Zhao H; Zhou W; Guo X; Chen C; Li X
    J Exp Clin Cancer Res; 2022 Oct; 41(1):301. PubMed ID: 36229838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.